Snowflake director Frank Slootman sells 300,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman exercised options for 300,000 shares at an $8.88 exercise price on November 18 and 19, 2026, and sold 300,000 shares across multiple transactions on those dates. The exercises and sales were made under a Rule 10b5-1 trading plan adopted September 19, 2025. The options were fully vested.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F27 | 74,647 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 74,647 | $8.88 | $663K |
| Sale | Common Stock F1, F14, F2 | 381 | $288.67 | $110K |
| Sale | Common Stock F1, F15, F2 | 5,930 | $290.271 | $1.72M |
| Sale | Common Stock F1, F16, F2 | 6,148 | $291.203 | $1.79M |
| Sale | Common Stock F1, F17, F2 | 10,632 | $292.491 | $3.11M |
| Sale | Common Stock F1, F18, F2 | 17,204 | $293.362 | $5.05M |
| Sale | Common Stock F1, F19, F2 | 19,784 | $294.29 | $5.82M |
| Sale | Common Stock F1, F20, F2 | 11,993 | $295.20 | $3.54M |
| Sale | Common Stock F1, F21, F2 | 2,575 | $296.303 | $763K |
| Exercise | Stock Option (Right to Buy) F1, F27 | 225,353 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 225,353 | $8.88 | $2.00M |
| Sale | Common Stock F1, F3, F2 | 2,320 | $269.807 | $626K |
| Sale | Common Stock F1, F4, F2 | 1,895 | $271.032 | $514K |
| Sale | Common Stock F1, F5, F2 | 6,678 | $272.155 | $1.82M |
| Sale | Common Stock F1, F6, F2 | 1,983 | $273.542 | $542K |
| Sale | Common Stock F1, F7, F2 | 12,915 | $274.462 | $3.54M |
| Sale | Common Stock F1, F8, F2 | 30,912 | $275.62 | $8.52M |
| Sale | Common Stock F1, F9, F2 | 36,208 | $276.485 | $10.01M |
| Sale | Common Stock F1, F10, F2 | 25,152 | $277.586 | $6.98M |
| Sale | Common Stock F1, F11, F2 | 78,613 | $278.505 | $21.89M |
| Sale | Common Stock F1, F12, F2 | 28,334 | $279.324 | $7.91M |
| Sale | Common Stock F1, F13, F2 | 343 | $280.075 | $96K |
| Holding | Common Stock F22 | -- | -- | -- |
| Holding | Common Stock F23 | -- | -- | -- |
| Holding | Common Stock F24 | -- | -- | -- |
| Holding | Common Stock F25 | -- | -- | -- |
| Holding | Common Stock F26 | -- | -- | -- |
Footnotes (27)
- F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.760 to $270.470, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.800 to $271.670, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.830 to $272.725, inclusive.
- F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.940 to $273.870, inclusive.
- F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.950 to $274.855, inclusive.
- F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.980 to $275.965, inclusive.
- F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $275.980 to $276.970, inclusive.
- F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $276.990 to $277.965, inclusive.
- F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $277.990 to $278.982, inclusive.
- F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $278.990 to $279.985, inclusive.
- F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $279.995 to $280.160, inclusive.
- F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $288.505 to $289.370, inclusive.
- F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $289.795 to $290.770, inclusive.
- F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $290.815 to $291.770, inclusive.
- F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $291.820 to $292.816, inclusive.
- F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $292.820 to $293.815, inclusive.
- F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $293.820 to $294.800, inclusive.
- F20. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $294.820 to $295.800, inclusive.
- F21. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $295.970 to $296.880, inclusive.
- F22. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
- F23. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F24. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F25. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F26. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F27. The stock option is fully vested.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted-average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the exercise price for Frank Slootman's SNOW option exercises?
AI-generated analysis. How Rhea-AI works. Not financial advice.